- $39.85bn
- $38.01bn
- $2.13bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 363 | 603 | 1,029 | 1,675 | 2,128 |
Cost of Revenue | |||||
Gross Profit | 274 | 473 | 795 | 1,328 | 1,718 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 383 | 617 | 1,048 | 1,734 | 2,162 |
Operating Profit | -20.1 | -13.8 | -19.2 | -58.7 | -33.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16 | -22.2 | -18.4 | -38.1 | 60.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.7 | -24.5 | -20.7 | -50.2 | 48.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -16.7 | -24.5 | -20.7 | -50.2 | 48.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.7 | -24.5 | -20.7 | -50.2 | 48.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.056 | -0.082 | -0.067 | -0.159 | 0.139 |